iifl-logo-icon 1

Lupin Ltd Share Price

1,824.5
(1.49%)
Jul 15, 2024|12:39:59 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open1,819.95
  • Day's High1,825
  • 52 Wk High1,834.5
  • Prev. Close1,797.75
  • Day's Low1,801.25
  • 52 Wk Low921.9
  • Turnover (lac)8,872.85
  • P/E35.58
  • Face Value2
  • Book Value451.86
  • EPS50.51
  • Mkt. Cap (Cr.)83,189.7
  • Div. Yield0.44
Loading...
  • Open1,814.95
  • Day's High1,828.4
  • Spot1,821.7
  • Prev. Close1,796.15
  • Day's Low1,800
  • ViewLong BuildUp
  • Market Lot425
  • OI(Chg %)1,11,780 (1.06%)
  • Roll Over%0.46
  • Roll Cost1.35
  • Traded Vol.12,58,850 (-5.12%)
View More Futures

Lupin Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

1,819.95

Prev. Close

1,797.75

Turnover(Lac.)

8,872.85

Day's High

1,825

Day's Low

1,801.25

52 Week's High

1,834.5

52 Week's Low

921.9

Book Value

451.86

Face Value

2

Mkt Cap (₹ Cr.)

83,189.7

P/E

35.58

EPS

50.51

Divi. Yield

0.44

Lupin Ltd Corporate Action

22 Apr 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

4 Jul 2023

12:00 AM

AGM

Announcement Date: 04 Jul, 2023

arrow

9 May 2023

12:00 AM

Dividend

Dividend Amount: 4

Record Date: 14 Jul, 2023

arrow

Lupin Ltd NEWS AND UPDATE

Top 10 stocks for today – 15th July, 2024
15 Jul 2024|08:59 AM

Here are some of the stocks that may see significant price movement today: HCL Technologies, Lupin, Piramal Pharma, etc.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Lupin Ltd SHAREHOLDING SNAPSHOT

15 Jul, 2024|01:01 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 0.28%

Foreign: 0.28%

Indian: 46.70%

Non-Promoter- 46.11%

Institutions: 46.10%

Non-Institutions: 6.91%

Custodian: 0.00%

Share Price

Lupin Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

91.22

91

90.9

90.79

Preference Capital

0

0

0

0

Reserves

20,511.87

18,320.86

18,059.29

18,474.78

Net Worth

20,603.09

18,411.86

18,150.19

18,565.57

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

11,771.67

11,055.93

11,025.66

10,080.58

yoy growth (%)

6.47

0.27

9.37

-20.16

Raw materials

-4,467.26

-4,182.31

-4,207.27

-3,474.35

As % of sales

37.94

37.82

38.15

34.46

Employee costs

-1,918.16

-1,695.86

-1,703.22

-1,441.64

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

-161.53

1,629.7

1,811.46

1,793.93

Depreciation

-514.19

-502.83

-518.75

-389.81

Tax paid

-27.17

-371.08

-324.7

-449.27

Working capital

-135.75

-894.67

-203.16

1,003.92

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

6.47

0.27

9.37

-20.16

Op profit growth

-89.76

7.15

-8.54

-53.5

EBIT growth

-105.27

-10.39

2.01

-56.58

Net profit growth

-114.99

72.99

-45.89

-57.19

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

19,656.34

16,269.98

16,192.79

14,926.99

15,142.8

Excise Duty

0

0

0

0

0

Net Sales

19,656.34

16,269.98

16,192.79

14,926.99

15,142.8

Other Operating Income

354.48

371.68

212.69

235.97

231.96

Other Income

120.17

73.36

142.05

137.62

617.8

Lupin Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,577.3

124.083,78,675.04867.60.865,536.9998.75

Cipla Ltd

CIPLA

1,512.05

32.871,22,092.681,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,539.3

76.441,20,480.265310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,175.15

34.281,18,217.41,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,719.45

26.171,12,137.091,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Lupin Ltd

Management

Register Office

Registrar Office

Chairman (Non-Executive)

M D Gupta

Managing Director

Nilesh Deshbandhu Gupta.

Director & Chief Executive Off

Vinita Gupta

Company Sec. & Compli. Officer

R V Satam

Independent Director

Jean-Luc Belingard

Executive Director & CFO

Ramesh Swaminathan

Independent Director

Mark D McDade

Independent Director

K B S Anand

Independent Director

Punita Kumar Sinha

Independent Director

Jeffrey Kindler

Independent Director

Alfonso Zulueta

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments.Lupin Ltd was incorporated in the year 1983 with the name Lupin Chemicals Ltd. In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar. In the year 1989, the company established a joint venture in Thailand, namely Lupin Chemicals (Thailand) Ltd. In the year 1991, they initiated production of Injectable cephalosporin (bulk and dosages) at Mandideep. In the year 1992, the company set up Fermentation Plant at Tarapur, Maharashtra. Also, Sterile Plant for injectable Cephalosporins (bulk) was commissioned at Mandideep.In the year 2001, Lupin Laboratories Ltd was amalgamated with the company and the name was changed to Lupin Ltd. They commenced supply of Cephalosporin bulk actives to their alliance partners in the US. Also, they commissioned a state of the art US FDA approvable oral cephalosporin bulk active plant. In the year 2002, the company commissioned the new Anti-TB facility at Aurangabad. In the year 2003, the
Read More

Company FAQs

What is the Lupin Ltd share price today?

Down Arrow

The Lupin Ltd shares price on N/A is Rs.₹1829.65 today.

What is the Market Cap of Lupin Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Lupin Ltd is ₹83424.52 Cr. as of 15 Jul ‘24

What is the PE and PB ratio of Lupin Ltd?

Down Arrow

The PE and PB ratios of Lupin Ltd is 35.58 and 3.98 as of 15 Jul ‘24

What is the 52 Week High and Low of Lupin Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Lupin Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Lupin Ltd is ₹922.55 and ₹1837 as of 15 Jul ‘24

What is the CAGR of Lupin Ltd?

Down Arrow

Lupin Ltd's CAGR for 5 Years at 18.72%, 3 Years at 15.97%, 1 Year at 91.13%, 6 Month at 28.51%, 3 Month at 10.71% and 1 Month at 11.94%.

What is the shareholding pattern of Lupin Ltd?

Down Arrow

The shareholding pattern of Lupin Ltd is as follows:
Promoters - 46.98 %
Institutions - 46.10 %
Public - 6.92 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.